Ibrutinib-induced rapid response in chemotherapy-refractory Richter's Syndrome

被引:0
|
作者
Fischer-Maranta, A. [1 ]
Bastian, S. [1 ]
Mey, U. [1 ]
Cogliatti, S. [2 ]
Hohloch, K. [1 ,3 ]
机构
[1] Kantonspital Graubunden, Hamatol & Onkol, Chur, Switzerland
[2] Kantonspital St Gallen, Inst Pathol, St Gallen, Switzerland
[3] Uniklin Goettingen, Hamatol Onkol, Gottingen, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P534
引用
收藏
页码:157 / 157
页数:1
相关论文
共 50 条
  • [41] Transformation of Chronic Lymphocytic Leukemia Towards Richter's Syndrome Is Induced By AKT Activation
    Nickel, Nadine
    Al-Maarri, Mona
    Pal, Martin
    Roth, Andreas
    Knittel, Gero
    Herling, Carmen D.
    Reinart, Nina
    Schafer, Stephan
    Hartmann, Elena M.
    Rosenwald, Andreas
    Klapper, Wolfram
    Buttner, Reinhard
    Herling, Marco
    Bruening, Jens
    Reinhardt, Christian
    Hallek, Michael
    Wunderlich, Thomas
    Pallasch, Christian
    BLOOD, 2016, 128 (22)
  • [42] Uncommon syndromes and treatment manifestations of malignancy - Case 3. Richter's syndrome heralded by refractory hypercalcemia
    Freeman, NJ
    Holik, D
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (01) : 170 - 172
  • [43] A case report of response to crizotinib in chemotherapy-refractory metastatic gallbladder cancer with met amplification and acquired resistance resulting from the loss of MET amplification
    Sun, Hongna
    Li, Xiaofen
    Dai, Shuang
    Shen, Xudong
    Qiu, Meng
    PRECISION CLINICAL MEDICINE, 2021, 4 (03) : 209 - 214
  • [44] Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformation
    Hodkinson, Brendan P.
    Schaffer, Michael
    Brody, Joshua D.
    Jurczak, Wojciech
    Carpio, Cecilia
    Ben-Yehuda, Dina
    Avivi, Irit
    Forslund, Ann
    Ozcan, Muhit
    Alvarez, John
    Ceulemans, Rob
    Fourneau, Nele
    Younes, Anas
    Balasubramanian, Sriram
    TRANSLATIONAL ONCOLOGY, 2021, 14 (01):
  • [45] Rapid progression to Richter's syndrome in a patient with chronic lymphocytic leukemia and near-triploid karyotype
    Dencic-Fekete, Marija
    Terzic, Tatjana
    Jakovic, Ljubomir
    Djurasinovic, Vladislava
    Djurasevic, Teodora Karan
    Radojkovic, Milica
    Pavlovic, Sonja
    Bogdanovic, Andrija
    VOJNOSANITETSKI PREGLED, 2023, 80 (05) : 454 - 457
  • [46] Rapid response of severe refractory metastatic Crohn's disease to infliximab
    Miller, AM
    Elliott, PR
    Fink, R
    Connell, W
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2001, 16 (08) : 940 - 942
  • [47] Chemotherapy-refractory diffuse large B-cell lymphomas (DLBCL) are effectively killed by ofatumumab-induced complement-mediated cytoxicity
    Cillessen, Saskia A. G. M.
    Mackus, Wendy J. M.
    Castricum, Kitty C. M.
    Vos, Wim
    Kortman, Pim C.
    van de Winkel, Jan G. J.
    Parren, Paw W. H. I.
    Meijer, Chris J. L. M.
    Oudejans, Joost J.
    BLOOD, 2007, 110 (11) : 694A - 694A
  • [48] Reduced-Intensity Allogeneic Stem Cell Transplantation for Co-Emergence of Chemotherapy-Refractory Follicular Lymphoma and Therapy-Related Myelodysplastic Syndrome
    Shimura, Yuji
    Kuroda, Junya
    Sasaki, Nana
    Uchiyama, Hitoji
    Ohshiro, Muneo
    Matsumura, Yayoi
    Nagoshi, Hisao
    Mizutani, Shinsuke
    Kobayashi, Tsutomu
    Matsumoto, Yosuke
    Horiike, Shigeo
    Taniwaki, Masafumi
    CASE REPORTS IN ONCOLOGY, 2014, 7 (01): : 188 - 194
  • [49] Remarkable response to chidamide plus rituximab in an elderly patient with recurrent, chemotherapy-refractory diffuse larger B-cell lymphoma carrying CREBBP mutation
    Dongdong Zhang
    Yidi Han
    Youhong Dong
    Annals of Hematology, 2023, 102 : 1265 - 1268
  • [50] Remarkable response to chidamide plus rituximab in an elderly patient with recurrent, chemotherapy-refractory diffuse larger B-cell lymphoma carrying CREBBP mutation
    Zhang, Dongdong
    Han, Yidi
    Dong, Youhong
    ANNALS OF HEMATOLOGY, 2023, 102 (05) : 1265 - 1268